Breast Implants, Silicone Breast Implants | featured news

FDA questions studies of breast implant safety

FDA questions studies of breast implant safety

A U.S. Food and Drug Administration advisory panel began a two-day meeting Tuesday on silicone breast implants to consider ways to improve the effectiveness of post-approval safety studies.

 

FDA says decision to put silicone breast implants back on market was the right one

FDA says decision to put silicone breast implants back on market was the right one

The FDA was criticized in 2006 for approving the controversial implants after they'd been off the market for 14 years. But the organization says research in the last five years has shown the implants have 'reasonable assurance of safety and effectiveness.'

Senh: Isn't there a conflict of interest here? The study was conducted by the manufacturers of the implants.

 

Subscribe to this RSS topic: Syndicate content